Skip to main content
. 2015 Mar 31;100(6):2463–2471. doi: 10.1210/jc.2015-1050

Table 4.

Regression Coefficients Between Changes in BMD (24 Months—Baseline) and Clinical Parameters and Biomarkers

Men (n = 46–108)
Premenopausal Women (n = 28–29)
Postmenopausal Women (n = 55–100)
Sex × Predictor
ΔSpine BMD (24–0) P Value ΔFN BMD (24–0) P Value ΔSpine BMD (24–0) P Value ΔFN BMD (24–0) P Value ΔSpine BMD (24–0) P Value ΔFN BMD (24–0) P Value Spine BMD FN BMD
Age −0.0001 .731 0.0003 .359 −0.0003 .825 −0.0008 .502 0.0004 .537 0.0003 .659 0.265 0.968
Baseline data
    Weight, kg 0.0002 .547 −0.0005 .076 −0.00002 .976 0.0001 .908 0.0001 .697 0.0001 .766 0.462 0.292
    BMI 0.0007 .503 −0.0015 .102 0.0003 .868 0.0014 .459 0.0009 .299 0.0008 .353 0.987 0.096
    Waist circumference, cm 0.0001 .783 −0.0006 .065 −0.0004 .546 0.0002 .775 0.0004 .270 −0.0002 .645 0.974 0.580
    Body fat, % −0.0009 .229 −0.0001 .861 0.0001 .972 0.0002 .927 0.0005 .551 0.0001 .880 0.057 0.575
    FMI −0.0006 .671 −0.0011 .413 −0.0001 .972 0.0019 .527 −0.0005 .551 0.007 .560 0.164 0.253
    LM, % 0.0009 .229 0.0001 .861 −0.0001 .972 −0.0002 .927 −0.0005 .551 −0.0001 .880 0.057 0.575
    LMI 0.0033 .076 −0.0035 .043 0.0007 .844 0.0025 .486 0.0018 .357 0.0026 .205 0.198 0.097
    Fat/LM ratio −0.0405 .258 −0.0039 .907 −0.0006 .993 0.0105 .888 0.0161 .542 0.0086 .975 0.040 0.606
    VATa 0.0016 .629 −0.0042 .111 N/Aa N/Aa N/Aa N/Aa 0.0045 .131 −0.0015 .624 0.507 0.514
    SATa 0.0026 .156 −0.0024 .099 N/Aa N/Aa N/Aa N/Aa −0.0013 .473 0.0003 .871 0.130 0.264
    Physical activity 0.0304 .393 0.0303 .368 −0.0584 .463 0.1044 .189 −0.0165 .576 0.0399 .187 0.282 0.911
Follow-up data (24–0 mo)
    ΔWeight −0.0010 .006 0.0003 .322 −0.0001 .933 0.0032 .010 0.0016 .004 0.0022 <.0001 <0.0001 0.001
    ΔBMI −0.0032 .005 0.0011 .287 −0.0003 .941 0.0083 .011 0.0042 .004 0.0061 <.0001 <0.0001 0.003
    ΔWaist circumference −0.0008 .024 0.0004 .231 0.00005 .962 0.0017 .108 0.0009 .086 0.0015 .004 0.006 0.049
    ΔBody fat, % −0.0004 .026 0.0001 .444 −0.0001 .877 0.0013 .024 0.0007 .006 0.0011 <.0001 0.0004 <0.001
    ΔFMI −0.0037 .027 0.0014 .365 −0.0003 .952 0.0105 .015 0.0053 .007 0.0080 <.0001 0.0004 0.006
    ΔLM, % 0.0004 .026 0.0006 .328 0.0001 .877 0.0039 .044 0.0007 .006 0.0029 <.001 <0.0001 0.025
    ΔLMI −0.0100 .001 0.003 .248 −0.0017 .869 0.0194 .0502 0.0119 .011 0.0149 .002 <0.0001 0.019
    ΔFM/LM mass ratio −0.0613 .171 0.0325 .444 −0.0012 .987 0.1909 .030 0.0996 .016 0.1619 <.0001 0.007 0.026
    ΔVAT −0.0060 .063 0.0017 .523 N/A* N/A* N/A* N/A* 0.0120 .031 0.0230 <.0001 0.007 <0.001
    ΔSAT −0.0086 .003 0.00002 .995 N/A* N/A* N/A* N/A* 0.0062 .037 0.0101 .0002 0.0003 0.005
    ΔPhysical activity 0.0557 .152 0.0011 .976 0.0717 .414 −0.0835 .346 0.0672 .047 −0.0520 .139 0.863 0.310

Abbreviations: SAT, sc adipose tissue; N/A, not available. Menopausal status was self-reported at enrollment.

a

For CT measures (VAT and SAT), n = 42 postmenopausal women, 0 premenopausal women, and 55 men.